CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in CORT — Corcept Therapeutics Inc
CIK 884546
SAN FRANCISCO, CA
Position in CORT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$100,651,581
+$55,506,034 QoQ
Shares Held
1,157,580
+3.4% QoQ
Ownership
1.07%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#15
of 423 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CORT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. CORT ranks #17 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in CORT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $100,651,581 | 1,157,580 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $45,145,547 | 1,119,959 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $36,961,114 | 1,062,101 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $88,951,053 | 1,070,281 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $59,780,997 | 814,455 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $117,843,515 | 1,031,724 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $52,988,108 | 1,051,560 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $47,505,818 | 1,026,487 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $31,622,387 | 973,296 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $23,513,882 | 933,461 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $29,246,421 | 900,444 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $23,471,324 | 861,333 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $18,772,258 | 843,697 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $19,276,598 | 889,963 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $18,077,443 | 890,076 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $21,092,925 | 822,657 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $19,385,265 | 815,192 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $17,694,324 | 785,716 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $13,459,347 | 679,765 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $15,063,800 | 765,437 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $16,841,924 | 765,542 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $18,803,830 | 790,409 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $19,985,062 | 763,955 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $13,053,704 | 749,782 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $12,881,731 | 765,858 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $8,220,508 | 691,380 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||